During the past decade, Spokane Internal Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spokane Internal Medicine" #1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Spokane Internal Medicine" are "Diabetes" (2 trials), "Diabetic Neuropathy, Painful" (1 trials), "Irritable Bowel Syndrome" (1 trials), "Opioid Induced Constipation (OIC)" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Spokane Internal Medicine" in a lesser frequency.

Most popular intervention types in "Spokane Internal Medicine" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Saxagliptin" (2 trials), "Buprenorphine transdermal patch" (1 trials), "DDP733" (1 trials) and "Metformin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spokane Internal Medicine" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Spokane Internal Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Spokane Internal Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Spokane Internal Medicine, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".